Cargando…

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection

Patients after LT due to combined HBV/HDV infection are considered to be high-risk patients for recurrence of hepatitis B and D. To date, life-long prophylaxis with hepatitis B immunoglobulin (HBIG) and replication control with nucleos(t)ide analogs (NA) remains standard. We examined the course of 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ossami Saidy, Ramin Raul, Sud, Irina, Eurich, Franziska, Aydin, Mustafa, Postel, Maximilian Paul, Dobrindt, Eva Maria, Pratschke, Johann, Eurich, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153150/ https://www.ncbi.nlm.nih.gov/pubmed/34068217 http://dx.doi.org/10.3390/v13050904

Ejemplares similares

Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2020)

Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
por: Eurich, Dennis, et al.
Publicado: (2023)

A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2022)

Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival
por: Pesthy, Sina, et al.
Publicado: (2022)

The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022)

HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

Long-term Outcome of Orthotopic Liver Transplantation in Patients With Hemochromatosis: A Summary of a 30-year Transplant Program
por: Dobrindt, Eva Maria, et al.
Publicado: (2020)

Orthotopic Liver Transplantation for Budd-Chiari Syndrome: Observations from a 30-Year Liver Transplant Program
por: Ibach, Marius, et al.
Publicado: (2021)

Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival
por: Çetinkaya-Hosgör, Candan, et al.
Publicado: (2023)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

Anti-HDV seroprevalance among patients with previous HBV infection
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients
por: Schmidbauer, Caroline, et al.
Publicado: (2021)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
por: Yan, Huan, et al.
Publicado: (2023)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
por: Khan, Asad U, et al.
Publicado: (2011)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Evaluation of miR-222 Expression in HBV Infected Patients in Comparison with HDV and HBV Co-infected Patients
por: Sokhanvar, Zahra, et al.
Publicado: (2021)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
por: Molagic, Violeta, et al.
Publicado: (2013)

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy
por: Klein, Fritz, et al.
Publicado: (2016)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
por: Colagrossi, Luna, et al.
Publicado: (2018)

PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical Study
por: Riaz, Muhammad Nasir, et al.
Publicado: (2016)

Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
por: Scheller, Laura, et al.
Publicado: (2021)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

HDV-Like Viruses
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)

High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2020)

Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge
por: Lorenc, Beata, et al.
Publicado: (2017)

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
por: Tsuge, Masataka, et al.
Publicado: (2019)

Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response
por: Chida, Takeshi, et al.
Publicado: (2023)

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
por: Jachs, Mathias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfu3ik2n8bhh45tu7pnl3orqda